Potential immunological and genetic markers associated with lupus nephritis: From pathogenicity to therapeutic drug target

被引：1
|
作者：
Sharafaldin, Esra Nasraldin Khalil [1 ]
Huri, Hasniza Zaman [1 ,2 ]
Sim, Maw Shin [3 ]
Lim, Soo Kun [4 ]
机构：
[1] Univ Malaya, Fac Pharm, Dept Clin Pharm & Pharm Practice, Kuala Lumpur 50603, Malaysia
[2] Univ Malaya, Med Ctr, Clin Invest Ctr, Kuala Lumpur 50603, Malaysia
[3] Univ Malaya, Fac Pharm, Dept Pharmaceut Life Sci, Kuala Lumpur 50603, Malaysia
[4] Univ Malaya, Fac Med, Dept Med, Renal Div, Kuala Lumpur 59100, Malaysia
来源：
AUTOIMMUNITY REVIEWS | 2023年 / 22卷 / 12期
关键词：
D O I：
10.1016/j.autrev.2023.103406
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Podocytes and autophagy: a potential therapeutic target in lupus nephritis
    Zhou, Xu-Jie
    Klionsky, Daniel J.
    Zhang, Hong
    AUTOPHAGY, 2019, 15 (05) : 908 - 912
  • [2] Endoplasmic Reticulum Stress in Systemic Lupus Erythematosus and Lupus Nephritis: Potential Therapeutic Target
    Li, Hui-Yuan
    Huang, Li-Feng
    Huang, Xiao-Rong
    Wu, Dan
    Chen, Xiao-Cui
    Tang, Ji-Xin
    An, Ning
    Liu, Hua-Feng
    Yang, Chen
    JOURNAL OF IMMUNOLOGY RESEARCH, 2023, 2023
  • [3] Therapeutic drug monitoring of mycophenolic acid: a potential treatment for lupus nephritis
    Pawinski, Tomasz
    KIDNEY INTERNATIONAL, 2010, 78 (04) : 335 - 336
  • [4] IMMUNOLOGICAL AND DEMOGRAPHIC FACTORS ASSOCIATED WITH LUPUS NEPHRITIS
    Alba, P.
    Bento, L.
    Karim, M. Y.
    Cuadrado, M. J.
    Abbs, I. C.
    Tungekar, M. F.
    D'Cruz, D. P.
    Khamashta, M. A.
    Hughes, G. R. V.
    RHEUMATOLOGY, 2002, 41 : 105 - 106
  • [5] Pim-1 As a Therapeutic Target in Lupus Nephritis
    Fu, Rong
    Xia, Yong
    Li, Meirong
    Mao, Renxiang
    Guo, Chaohuan
    Zhou, Mianjing
    Tan, Hechang
    Liu, Meiling
    Wang, Shuang
    Yang, Niansheng
    Zhao, Jijun
    ARTHRITIS & RHEUMATOLOGY, 2019, 71 (08) : 1308 - 1318
  • [6] CAN PLASMAPHERESIS IMPROVE LUPUS NEPHRITIS WITHOUT ITS IMMUNOLOGICAL MARKERS
    AMATO, M
    SALVADORI, M
    NEPHRON, 1988, 48 (03): : 252 - 253
  • [7] Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritis
    Jing, Chenzhi
    Castro-Dopico, Tomas
    Richoz, Nathan
    Tuong, Zewen K.
    Ferdinand, John R.
    Lok, Laurence S. C.
    Loudon, Kevin W.
    Banham, Gemma D.
    Mathews, Rebeccah J.
    Cader, Zaeem
    Fitzpatrick, Susan
    Bashant, Kathleen R.
    Kaplan, Mariana J.
    Kaser, Arthur
    Johnson, Randall S.
    Murphy, Michael P.
    Siegel, Richard M.
    Clatworthy, Menna R.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (26) : 15160 - 15171
  • [8] Clinical and Immunological Factors Associated with the Progression of Lupus Nephritis in a Population from the Colombian Caribbean
    Velez-Verbel, Maria
    Aroca-Martinez, Gustavo
    Velez-Verbel, David
    Dominguez-Vargas, Alex
    Vallejo-Patino, Manuela
    Sarmiento-Gutierrez, Joanny
    Gomez-Escorcia, Lorena
    Musso, Carlos G.
    Gonzalez-Torres, Henry J.
    BIOMEDICINES, 2024, 12 (09)
  • [9] The Complex Role of Gut Microbiota in Systemic Lupus Erythematosus and Lupus Nephritis: From Pathogenetic Factor to Therapeutic Target
    Parodi, Emanuele
    Novi, Marialuisa
    Bottino, Paolo
    La Porta, Edoardo
    Merlotti, Guido
    Castello, Luigi Mario
    Gotta, Franca
    Rocchetti, Andrea
    Quaglia, Marco
    MICROORGANISMS, 2025, 13 (02)
  • [10] Semaphorin3A: A Potential Therapeutic Tool for Lupus Nephritis
    Bejar, Jacob
    Kessler, Ofra
    Sabag, Adi D.
    Sabo, Edmond
    Ben Itzhak, Ofer
    Neufeld, Gera
    Vadasz, Zahava
    FRONTIERS IN IMMUNOLOGY, 2018, 9
12345